Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of Letrozole in the Treatment of Endometrial Cancer
This study has been completed.
Study NCT00333086   Information provided by Novartis

First Received on June 1, 2006.   Last Updated on April 18, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Adenoma
Endometrial Neoplasms
Sarcoma, Endometrial Stromal
More general conditions related to this trial
Endometrial Stromal Tumors
Genital Diseases, Female
Genital Neoplasms, Female
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Complex and Mixed
Neoplasms, Connective and Soft Tissue
Neoplasms, Glandular and Epithelial
Sarcoma
Urogenital Neoplasms
Uterine Diseases
Uterine Neoplasms
Interventions listed in this trial
Letrozole
Additional drug interventions recognized in this trial
Aromatase Inhibitors
More general drug interventions related to this trial
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Novartis Pharmaceuticals
NCIC CTG


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services